VERSO BIOSENSE R&D LIMITED

(Company Number 09890252)

Registered office: MHA Advisory Ltd, 6th Floor, 2 London Wall Place, London, EC2Y 5AU (Formerly) 115b Innovation Drive, Milton Park, Milton, Abingdon, Oxfordshire, OX14 4RZ

Principal trading address: N/A

NOTICE IS GIVEN by Nicola Kate Clark (IP No. 19390) of MHA Advisory Limited, 80 Mosley Street, Manchester, M2 3FX and Andrew John Duncan (IP No. 9319) of MHA Advisory Limited, 6th Floor, 2 London Wall Place, London, EC2Y 5AU the Joint Liquidators of the above-named company, which was wound up voluntarily on 23 September 2026 that a first and final distribution is going to be made.

Creditors of the Company are required, on or before 26 October 2026 to send their full names and addresses together with full particulars of their debts or claims to MHA Advisory Ltd, 6th Floor, 2 London Wall Place, London, EC2Y 5AU and, if so requested, to provide such further details or produce such documentary or other evidence as may appear to be necessary. A creditor who has not proved their debt before the above date, or who increases the claim in their proof after that date, will be excluded from the benefit of any distribution made before such debts are proved. Please note that the distribution may be made without regard to the claim of any person in respect of a debt not proved.

Please note that after paying or providing for a final distribution in respect of the claims of all creditors who have proved their debts, the funds remaining in the hands of the Liquidators shall be distributed to shareholders absolutely.

Note: The Director of the Company has made a declaration of solvency and it is expected that all creditors will be paid in full.

Further details contact: Fahad Mohammed, Email: fahad.mohammed@mha.co.uk, Tel: 020 8146 2375.

Nicola Clark, Joint Liquidator

23 September 2026

Ag UK62550